Detalles de la búsqueda
1.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462870
2.
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
J Transl Med
; 19(1): 270, 2021 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34167578
3.
Response to cabozantinib in renal cell carcinoma with cardiac metastases.
Anticancer Drugs
; 31(3): 314-318, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31929349
4.
Facing SARS-CoV-2 outbreak in immunotherapy era.
Future Oncol
; 16(20): 1475-1485, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32468851
5.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796151
6.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 22(12): 1463-1469, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28860412
7.
Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports.
Stud Health Technol Inform
; 314: 98-102, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38785011
8.
Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib.
Crit Rev Oncol Hematol
; 194: 104243, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38135019
9.
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
Clin Lung Cancer
; 25(2): 190-195, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262770
10.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 23(2): 272, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449512
11.
Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers.
Curr Oncol
; 30(2): 2366-2387, 2023 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36826142
12.
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.] / Gestione del paziente con microcitoma a stadio esteso. L'importanza della collaborazione tra oncologia e radioterapia.
Recenti Prog Med
; 114(7): 414-425, 2023.
Artículo
en Italiano
| MEDLINE | ID: mdl-37392104
13.
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists - INTERACTION group.
Crit Rev Oncol Hematol
; 190: 104108, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37633350
14.
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Clin Cancer Res
; 29(14): 2714-2724, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37125965
15.
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis.
J Chemother
; 34(2): 123-132, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34313188
16.
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients.
Cancers (Basel)
; 14(10)2022 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35626040
17.
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP).
Lung Cancer
; 174: 118-124, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36379124
18.
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.
J Hematol Oncol
; 15(1): 9, 2022 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35062993
19.
[Detection of novel driver mutations in liquid biopsy: case report of a RET-positive lung adenocarcinoma treated with pralsetinib.] / Identificazione di mutazioni driver nel tumore del polmone non a piccole cellule mediante biopsia liquida: fusione di RET e terapia con pralsetinib.
Recenti Prog Med
; 112(1): 5e-9e, 2021 01.
Artículo
en Italiano
| MEDLINE | ID: mdl-33512366
20.
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis.
Cancers (Basel)
; 13(4)2021 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33562011